Controlling the Dissociation of Ligands from the Adenosine A_2A Receptor through Modulation of Salt Bridge Strength

Click to copy article linkArticle link copied!

This article is cited by 143 publications.

1. Victor Tänzel, Miriam Jäger, Steffen Wolf. Learning Protein–Ligand Unbinding Pathways via Single-Parameter Community Detection. Journal of Chemical Theory and Computation 2024, 20 (12) , 5058-5067. https://doi.org/10.1021/acs.jctc.4c00250
2. Margarita Stampelou, Graham Ladds, Antonios Kolocouris. Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A3 Receptor. The Journal of Physical Chemistry B 2024, 128 (4) , 914-936. https://doi.org/10.1021/acs.jpcb.3c05986
3. Steffen Wolf. Predicting Protein–Ligand Binding and Unbinding Kinetics with Biased MD Simulations and Coarse-Graining of Dynamics: Current State and Challenges. Journal of Chemical Information and Modeling 2023, 63 (10) , 2902-2910. https://doi.org/10.1021/acs.jcim.3c00151
4. Lucija Hok, Robert Vianello. Selective Deuteration Improves the Affinity of Adenosine A2A Receptor Ligands: A Computational Case Study with Istradefylline and Caffeine. Journal of Chemical Information and Modeling 2023, 63 (10) , 3138-3149. https://doi.org/10.1021/acs.jcim.3c00424
5. Efpraxia Tzortzini, Robin A. Corey, Antonios Kolocouris. Comparative Study of Receptor-, Receptor State-, and Membrane-Dependent Cholesterol Binding Sites in A2A and A1 Adenosine Receptors Using Coarse-Grained Molecular Dynamics Simulations. Journal of Chemical Information and Modeling 2023, 63 (3) , 928-949. https://doi.org/10.1021/acs.jcim.2c01181
6. Wei Liu, Jingsheng Jiang, Yating Lin, Qidong You, Lei Wang. Insight into Thermodynamic and Kinetic Profiles in Small-Molecule Optimization. Journal of Medicinal Chemistry 2022, 65 (16) , 10809-10847. https://doi.org/10.1021/acs.jmedchem.2c00682
7. Xueying Wang, Shuguang Yuan, H. C. Stephen Chan. Translocation Mechanism of Allosteric Sodium Ions in β2-Adrenoceptor. Journal of Chemical Information and Modeling 2022, 62 (12) , 3090-3095. https://doi.org/10.1021/acs.jcim.2c00170
8. Fazhi Yu, Chenyu Zhu, Shuyin Ze, Haojie Wang, Xinyu Yang, Mingyao Liu, Qiong Xie, Weiqiang Lu, Yonghui Wang. Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8H)-one Derivatives as Novel Potent Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. Journal of Medicinal Chemistry 2022, 65 (5) , 4367-4386. https://doi.org/10.1021/acs.jmedchem.1c02199
9. Alessandro Nicoli, Andreas Dunkel, Toni Giorgino, Chris de Graaf, Antonella Di Pizio. Classification Model for the Second Extracellular Loop of Class A GPCRs. Journal of Chemical Information and Modeling 2022, 62 (3) , 511-522. https://doi.org/10.1021/acs.jcim.1c01056
10. Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez-Autet, Natàlia Llopart, Estefanía Moreno, Nil Casajuana-Martin, Sergi Ferré, Leonardo Pardo, Vicent Casadó, Miriam Royo. Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer. Journal of Medicinal Chemistry 2022, 65 (1) , 616-632. https://doi.org/10.1021/acs.jmedchem.1c01763
11. Jin Cheng, Maozi Chen, Siyi Wang, Tianjian Liang, Hui Chen, Chih-Jung Chen, Zhiwei Feng, Xiang-Qun Xie. Binding Characterization of Agonists and Antagonists by MCCS: A Case Study from Adenosine A2A Receptor. ACS Chemical Neuroscience 2021, 12 (9) , 1606-1620. https://doi.org/10.1021/acschemneuro.1c00082
12. Tasia Amelia, Jacobus P. D. van Veldhoven, Matteo Falsini, Rongfang Liu, Laura H. Heitman, Gerard J. P. van Westen, Elena Segala, Grégory Verdon, Robert K. Y. Cheng, Robert M. Cooke, Daan van der Es, Adriaan P. IJzerman. Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor. Journal of Medicinal Chemistry 2021, 64 (7) , 3827-3842. https://doi.org/10.1021/acs.jmedchem.0c01856
13. Giuseppe Deganutti, Kerry Barkan, Barbara Preti, Michele Leuenberger, Mark Wall, Bruno G. Frenguelli, Martin Lochner, Graham Ladds, Christopher A. Reynolds. Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor. ACS Pharmacology & Translational Science 2021, 4 (1) , 314-326. https://doi.org/10.1021/acsptsci.0c00195
14. Fazhi Yu, Chenyu Zhu, Qiong Xie, Yonghui Wang. Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. Journal of Medicinal Chemistry 2020, 63 (21) , 12196-12212. https://doi.org/10.1021/acs.jmedchem.0c00237
15. Wijnand J. C. van der Velden, Laura H. Heitman, Mette M. Rosenkilde. Perspective: Implications of Ligand–Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors. ACS Pharmacology & Translational Science 2020, 3 (2) , 179-189. https://doi.org/10.1021/acsptsci.0c00012
16. Giuseppe Deganutti, Stefano Moro, Christopher A. Reynolds. A Supervised Molecular Dynamics Approach to Unbiased Ligand–Protein Unbinding. Journal of Chemical Information and Modeling 2020, 60 (3) , 1804-1817. https://doi.org/10.1021/acs.jcim.9b01094
17. Steffen Wolf, Marta Amaral, Maryse Lowinski, Francois Vallée, Djordje Musil, Jörn Güldenhaupt, Matthias K. Dreyer, Jörg Bomke, Matthias Frech, Jürgen Schlitter, Klaus Gerwert. Estimation of Protein–Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations. Journal of Chemical Information and Modeling 2019, 59 (12) , 5135-5147. https://doi.org/10.1021/acs.jcim.9b00592
18. Robin A. Corey, Owen N. Vickery, Mark S. P. Sansom, Phillip J. Stansfeld. Insights into Membrane Protein–Lipid Interactions from Free Energy Calculations. Journal of Chemical Theory and Computation 2019, 15 (10) , 5727-5736. https://doi.org/10.1021/acs.jctc.9b00548
19. David Schaller, Szymon Pach, Gerhard Wolber. PyRod: Tracing Water Molecules in Molecular Dynamics Simulations. Journal of Chemical Information and Modeling 2019, 59 (6) , 2818-2829. https://doi.org/10.1021/acs.jcim.9b00281
20. Giulio Mattedi, Francesca Deflorian, Jonathan S. Mason, Chris de Graaf, Francesco L. Gervasio. Understanding Ligand Binding Selectivity in a Prototypical GPCR Family. Journal of Chemical Information and Modeling 2019, 59 (6) , 2830-2836. https://doi.org/10.1021/acs.jcim.9b00298
21. Andrew Potterton, Fouad S. Husseini, Michelle W. Y. Southey, Mike J. Bodkin, Alexander Heifetz, Peter V. Coveney, Andrea Townsend-Nicholson. Ensemble-Based Steered Molecular Dynamics Predicts Relative Residence Time of A2A Receptor Binders. Journal of Chemical Theory and Computation 2019, 15 (5) , 3316-3330. https://doi.org/10.1021/acs.jctc.8b01270
22. Márton Vass, Sabina Podlewska, Iwan J. P. de Esch, Andrzej J. Bojarski, Rob Leurs, Albert J. Kooistra, Chris de Graaf. Aminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data. Journal of Medicinal Chemistry 2019, 62 (8) , 3784-3839. https://doi.org/10.1021/acs.jmedchem.8b00836
23. Yoonji Lee, Shaherin Basith, and Sun Choi . Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations. Journal of Medicinal Chemistry 2018, 61 (1) , 1-46. https://doi.org/10.1021/acs.jmedchem.6b01453
24. Lizi Xia, Henk de Vries, Eelke B. Lenselink, Julien Louvel, Michael J. Waring, Leifeng Cheng, Sara Pahlén, Maria J. Petersson, Peter Schell, Roine I. Olsson, Laura H. Heitman, Robert J. Sheppard, and Adriaan P. IJzerman . Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists. Journal of Medicinal Chemistry 2017, 60 (23) , 9545-9564. https://doi.org/10.1021/acs.jmedchem.7b00861
25. Francesca Spyrakis, Mostafa H. Ahmed, Alexander S. Bayden, Pietro Cozzini, Andrea Mozzarelli, and Glen E. Kellogg . The Roles of Water in the Protein Matrix: A Largely Untapped Resource for Drug Discovery. Journal of Medicinal Chemistry 2017, 60 (16) , 6781-6827. https://doi.org/10.1021/acs.jmedchem.7b00057
26. Jonathan Cramer, Stefan G. Krimmer, Veronica Fridh, Tobias Wulsdorf, Robert Karlsson, Andreas Heine, and Gerhard Klebe . Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin. ACS Chemical Biology 2017, 12 (1) , 225-233. https://doi.org/10.1021/acschembio.6b00979
27. Vincenzo Maria D’Amore, Paolo Conflitti, Luciana Marinelli, Vittorio Limongelli. Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A2A receptor activation mechanism. Chem 2024, 459 https://doi.org/10.1016/j.chempr.2024.08.004
28. Claudia Llinas del Torrent, Iu Raïch, Angel Gonzalez, Jaume Lillo, Nil Casajuana‐Martin, Rafael Franco, Leonardo Pardo, Gemma Navarro. Allosterism in the adenosine A 2A and cannabinoid CB 2 heteromer. British Journal of Pharmacology 2024, https://doi.org/10.1111/bph.16502
29. Gregory L. Szwabowski, Makenzie Griffing, Elijah J. Mugabe, Daniel O’Malley, Lindsey N. Baker, Daniel L. Baker, Abby L. Parrill. G Protein-Coupled Receptor–Ligand Pose and Functional Class Prediction. International Journal of Molecular Sciences 2024, 25 (13) , 6876. https://doi.org/10.3390/ijms25136876
30. Danislav S. Spassov. Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models. International Journal of Molecular Sciences 2024, 25 (13) , 7124. https://doi.org/10.3390/ijms25137124
31. Steffen Wolf. MD Simulations for D rug‐Target (Un)binding Kinetics. 2024, 45-64. https://doi.org/10.1002/9783527840748.ch3
32. Polina A. Khorn, Aleksandra P. Luginina, Vladimir A. Pospelov, Dmitrii E. Dashevsky, Andrey N. Khnykin, Olga V. Moiseeva, Nadezhda A. Safronova, Anatolii S. Belousov, Alexey V. Mishin, Valentin I. Borshchevsky. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: A Structural Biology Perspective. Biochemistry (Moscow) 2024, 89 (4) , 747-764. https://doi.org/10.1134/S0006297924040138
33. Fengping Zhan, Yanan Zhao, Xiaohui Dai, Jingbin Zeng, Qingxiang Wang. Electrochemically synthesized polyanine@Cu-BTC MOF as a bifunctional matrix for aptasensing of tetracycline in aquatic products. Microchemical Journal 2024, 196 , 109512. https://doi.org/10.1016/j.microc.2023.109512
34. Tobias Claff, Jonathan G. Schlegel, Jan H. Voss, Victoria J. Vaaßen, Renato H. Weiße, Robert K. Y. Cheng, Sandra Markovic-Mueller, Denis Bucher, Norbert Sträter, Christa E. Müller. Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. Communications Chemistry 2023, 6 (1) https://doi.org/10.1038/s42004-023-00894-6
35. A. O. Shpakov. Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction. Journal of Evolutionary Biochemistry and Physiology 2023, 59 (S1) , S1-S106. https://doi.org/10.1134/S0022093023070013
36. A. O. Shpakov. ALLOSTERIC SITES AND ALLOSTERIC REGULATORS OF G-PROTEIN-COUPLED RECEPTORS: GRAY CARDINALS OF SIGNAL TRANSDUCTION. Журнал эволюционной биохимии и физиологии 2023, 59 (7) , 559-658. https://doi.org/10.31857/S0044452923070021
37. Yassir Boulaamane, Iman Touati, Nainee Goyal, Anshuman Chandra, Lokesh Kori, Mahmoud A. A. Ibrahim, Mohammed Reda Britel, Amal Maurady. Exploring natural products as multi-target-directed drugs for Parkinson’s disease: an in-silico approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 2023, 100 , 1-18. https://doi.org/10.1080/07391102.2023.2260879
38. Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada, Tomoyuki Kanda, Mayumi Saki, Hikaru Miyagi, Mai Yasunaga, Chiyo Suno, So Iwata, Jun-ichi Saito, Shinichi Uchida. In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A 2A Receptor Antagonist/Inverse Agonist. Molecular Pharmacology 2023, 103 (6) , 311-324. https://doi.org/10.1124/molpharm.122.000633
39. Efpraxia Tzortzini, Antonios Kolocouris. Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A2A Adenosine Receptor. Biomolecules 2023, 13 (6) , 957. https://doi.org/10.3390/biom13060957
40. Wangli Miao, Dan Jia, Jie Xu, Li Yong, Zhongsheng Yi. Probing the binding interactions between perfluoroalkyl carboxylic acids and adenosine A2A receptors by spectroscopic techniques, molecular simulations and quantum chemistry. Journal of Molecular Liquids 2023, 377 , 121565. https://doi.org/10.1016/j.molliq.2023.121565
41. Marta Valle-León, Nil Casajuana-Martin, Claudia Llinas del Torrent, Josep Argerich, Laura Gómez-Acero, Kristoffer Sahlholm, Sergi Ferré, Leonardo Pardo, Francisco Ciruela. Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization. Biomedicine & Pharmacotherapy 2023, 160 , 114327. https://doi.org/10.1016/j.biopha.2023.114327
42. Zoe Li, Jie Liu, Fan Dong, Nancy Chang, Ruili Huang, Menghang Xia, Tucker A. Patterson, Huixiao Hong. Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor. International Journal of Molecular Sciences 2023, 24 (8) , 7042. https://doi.org/10.3390/ijms24087042
43. Jean-Louis Banères, Thomas Botzanowski, Jean A. Boutin, Barbara Calamini, Jérôme Castel, Laurent J. Catoire, Sarah Cianférani, Claire Demesmay, Gavin Ferguson, Gilles Ferry, Julie Kniazeff, Isabelle Krimm, Thierry Langer, Guillaume Lebon, Marie Ley, Miklos Nyerges, Magali Schwob, Catherine Venien-Bryan, Renaud Wagner, Gabrielle Zeder-Lutz, Claudia Zilian-Stohrer. Biophysical Dissection of Isolated GPCRs: The Adenosine A2A Receptor under the Bistouries. Receptors 2023, 2 (1) , 47-92. https://doi.org/10.3390/receptors2010004
44. Damien Cornut, Marine Soulié, Alexis Moreno, Gildas Nyame Mendendy Boussambe, Marjorie Damian, Sébastien Igonet, Pierre Guillet, Jean-Louis Banères, Grégory Durand. Non-ionic cholesterol-based additives for the stabilization of membrane proteins. Biochimie 2023, 205 , 27-39. https://doi.org/10.1016/j.biochi.2022.12.012
45. Wenqiang Cui, Junlin Dong, Shiyu Wang, Horst Vogel, Rongfeng Zou, Shuguang Yuan. Molecular basis of ligand selectivity for melatonin receptors. RSC Advances 2023, 13 (7) , 4422-4430. https://doi.org/10.1039/D2RA06693A
46. Andrea Spinaci, Michela Buccioni, Cui Chang, Diego Dal Ben, Beatrice Francucci, Catia Lambertucci, Rosaria Volpini, Gabriella Marucci. Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential. 2023, 101-141. https://doi.org/10.1007/7355_2023_162
47. Ri Han, Hongryul Yoon, Jiho Yoo, Yoonji Lee. Systematic analyses of the sequence conservation and ligand interaction patterns of purinergic P1 and P2Y receptors provide a structural basis for receptor selectivity. Computational and Structural Biotechnology Journal 2023, 21 , 889-898. https://doi.org/10.1016/j.csbj.2023.01.010
48. Yassir Boulaamane, Mahmoud A. A. Ibrahim, Mohammed Reda Britel, Amal Maurady. In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA 2A R antagonists for the treatment of Parkinson's disease. Journal of Integrative Bioinformatics 2022, 19 (4) https://doi.org/10.1515/jib-2021-0027
49. Laura I. Sarasola, Claudia Llinas del Torrent, Andrea Pérez-Arévalo, Josep Argerich, Nil Casajuana-Martín, Andy Chevigné, Víctor Fernández-Dueñas, Sergi Ferré, Leonardo Pardo, Francisco Ciruela. The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function. Biomedicine & Pharmacotherapy 2022, 156 , 113896. https://doi.org/10.1016/j.biopha.2022.113896
50. Geng Chen, Jun Xu, Asuka Inoue, Maximilian F. Schmidt, Chen Bai, Qiuyuan Lu, Peter Gmeiner, Zheng Liu, Yang Du. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex. Nature Communications 2022, 13 (1) https://doi.org/10.1038/s41467-022-30081-5
51. Taisei Yamamoto, Satoshi Yasuda, Rinshi S. Kasai, Ryosuke Nakano, Simon Hikiri, Kanna Sugaya, Tomohiko Hayashi, Satoshi Ogasawara, Mitsunori Shiroishi, Takahiro K. Fujiwara, Masahiro Kinoshita, Takeshi Murata. A methodology for creating mutants of G‐protein coupled receptors stabilized in active state by combining statistical thermodynamics and evolutionary molecular engineering. Protein Science 2022, 31 (10) https://doi.org/10.1002/pro.4425
52. Chenlin Feng, Xuesong Wang, Willem Jespers, Rongfang Liu, Sofía Denise Zamarbide Losada, Marina Gorostiola González, Gerard J. P. van Westen, Erik H. J. Danen, Laura H. Heitman. Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions. Molecules 2022, 27 (15) , 4676. https://doi.org/10.3390/molecules27154676
53. Abid Mahmood, Jamshed Iqbal. Purinergic receptors modulators: An emerging pharmacological tool for disease management. Medicinal Research Reviews 2022, 42 (4) , 1661-1703. https://doi.org/10.1002/med.21888
54. Kenneth A. Jacobson, Zhan‐Guo Gao, Pierre Matricon, Matthew T. Eddy, Jens Carlsson. Adenosine A 2A receptor antagonists: from caffeine to selective non‐xanthines. British Journal of Pharmacology 2022, 179 (14) , 3496-3511. https://doi.org/10.1111/bph.15103
55. Federico Del Signore, Paolo Marracino, Davide Cocco, Stefania Setti, Simona Salati, Ruggero Cadossi, Micaela Liberti, Francesca Apollonio. Magnetic Field Effects on the Binding Site of A 2A Receptor: An Insight Based on Atomistic Simulations. 2022, 1269-1273. https://doi.org/10.1109/MELECON53508.2022.9843056
56. Tobias Claff, Tim A. Klapschinski, Udaya K. Tiruttani Subhramanyam, Victoria J. Vaaßen, Jonathan G. Schlegel, Christin Vielmuth, Jan H. Voß, Jörg Labahn, Christa E. Müller. Eine einzige stabilisierende Punktmutation ermöglicht hochaufgelöste Co‐Kristallstrukturen des Adenosin‐A 2A ‐Rezeptors mit Preladenant‐Konjugaten. Angewandte Chemie 2022, 134 (22) https://doi.org/10.1002/ange.202115545
57. Tobias Claff, Tim A. Klapschinski, Udaya K. Tiruttani Subhramanyam, Victoria J. Vaaßen, Jonathan G. Schlegel, Christin Vielmuth, Jan H. Voß, Jörg Labahn, Christa E. Müller. Single Stabilizing Point Mutation Enables High‐Resolution Co‐Crystal Structures of the Adenosine A 2A Receptor with Preladenant Conjugates. Angewandte Chemie International Edition 2022, 61 (22) https://doi.org/10.1002/anie.202115545
58. William E. McIntire. A model for how Gβγ couples Gα to GPCR. Journal of General Physiology 2022, 154 (5) https://doi.org/10.1085/jgp.202112982
59. Davide Bassani, Matteo Pavan, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro. The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?. International Journal of Molecular Sciences 2022, 23 (9) , 4504. https://doi.org/10.3390/ijms23094504
60. Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, Bruce N. Cronstein, Rodrigo A. Cunha, . International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. Pharmacological Reviews 2022, 74 (2) , 340-372. https://doi.org/10.1124/pharmrev.121.000445
61. Jinan Wang, Apurba Bhattarai, Hung N. Do, Sana Akhter, Yinglong Miao. Molecular Simulations and Drug Discovery of Adenosine Receptors. Molecules 2022, 27 (7) , 2054. https://doi.org/10.3390/molecules27072054
62. Andrea Bortolato, Jonathan S. Mason. Discovery of HTL26119. 2022, 179-200. https://doi.org/10.1002/9781119627784.ch9
63. Rongfeng Zou, Xueying Wang, Shu Li, H. C. Stephen Chan, Horst Vogel, Shuguang Yuan. The role of metal ions in G protein‐coupled receptor signalling and drug discovery. WIREs Computational Molecular Science 2022, 12 (2) https://doi.org/10.1002/wcms.1565
64. Qianqian Zhang, Nannan Zhao, Xiaoxiao Meng, Fansen Yu, Xiaojun Yao, Huanxiang Liu. The prediction of protein–ligand unbinding for modern drug discovery. Expert Opinion on Drug Discovery 2022, 17 (2) , 191-205. https://doi.org/10.1080/17460441.2022.2002298
65. Dilip K. Tosh, Veronica Salmaso, Ryan G. Campbell, Harsha Rao, Amelia Bitant, Eline Pottie, Christophe P. Stove, Naili Liu, Oksana Gavrilova, Zhan-Guo Gao, John A. Auchampach, Kenneth A. Jacobson. A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity. European Journal of Medicinal Chemistry 2022, 228 , 113983. https://doi.org/10.1016/j.ejmech.2021.113983
66. Robert A. Copeland. Evolution of the drug-target residence time model. Expert Opinion on Drug Discovery 2021, 16 (12) , 1441-1451. https://doi.org/10.1080/17460441.2021.1948997
67. Qiankun Wang, Shan Zhang, Zhongjie Han, Huifang Fan, Chunhua Li. An investigation into the allosteric mechanism of GPCR A 2A adenosine receptor with trajectory-based information theory and complex network model. Journal of Biomolecular Structure and Dynamics 2021, 39 (17) , 6431-6439. https://doi.org/10.1080/07391102.2020.1799862
68. Javier García-Nafría, Christopher G. Tate. Structure determination of GPCRs: cryo-EM compared with X-ray crystallography. Biochemical Society Transactions 2021, 49 (5) , 2345-2355. https://doi.org/10.1042/BST20210431
69. Stefanie Kampen, Duc Duy Vo, Xiaoqun Zhang, Nicolas Panel, Yunting Yang, Mariama Jaiteh, Pierre Matricon, Per Svenningsson, Jose Brea, Maria Isabel Loza, Jan Kihlberg, Jens Carlsson. Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology. Angewandte Chemie 2021, 133 (33) , 18170-18178. https://doi.org/10.1002/ange.202101478
70. Stefanie Kampen, Duc Duy Vo, Xiaoqun Zhang, Nicolas Panel, Yunting Yang, Mariama Jaiteh, Pierre Matricon, Per Svenningsson, Jose Brea, Maria Isabel Loza, Jan Kihlberg, Jens Carlsson. Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology. Angewandte Chemie International Edition 2021, 60 (33) , 18022-18030. https://doi.org/10.1002/anie.202101478
71. Brennica Marlow, Georg Kuenze, Bian Li, Charles R. Sanders, Jens Meiler. Structural determinants of cholesterol recognition in helical integral membrane proteins. Biophysical Journal 2021, 120 (9) , 1592-1604. https://doi.org/10.1016/j.bpj.2021.02.028
72. Miles Congreve, John A. Christopher, Chris de Graaf. Structure‐Based Drug Design for G Protein‐Coupled Receptors. 2021, 1-59. https://doi.org/10.1002/0471266949.bmc269
73. Hung N. Do, Sana Akhter, Yinglong Miao. Pathways and Mechanism of Caffeine Binding to Human Adenosine A2A Receptor. Frontiers in Molecular Biosciences 2021, 8 https://doi.org/10.3389/fmolb.2021.673170
74. Jan Jakubík, Esam E. El-Fakahany. Allosteric Modulation of GPCRs of Class A by Cholesterol. International Journal of Molecular Sciences 2021, 22 (4) , 1953. https://doi.org/10.3390/ijms22041953
75. Veronica Salmaso, Shanu Jain, Kenneth A. Jacobson. Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization. 2021, 133-159. https://doi.org/10.1016/bs.mcb.2021.06.001
76. Ashley Ryan Vidad, Stephen Macaspac, Ho Leung Ng. Locating ligand binding sites in G-protein coupled receptors using combined information from docking and sequence conservation. PeerJ 2021, 9 , e12219. https://doi.org/10.7717/peerj.12219
77. Shunzhou Wan, Andrew Potterton, Fouad S. Husseini, David W. Wright, Alexander Heifetz, Maciej Malawski, Andrea Townsend-Nicholson, Peter V. Coveney. Hit-to-lead and lead optimization binding free energy calculations for G protein-coupled receptors. Interface Focus 2020, 10 (6) , 20190128. https://doi.org/10.1098/rsfs.2019.0128
78. Éva Bertalan, Samo Lešnik, Urban Bren, Ana-Nicoleta Bondar. Protein-water hydrogen-bond networks of G protein-coupled receptors: Graph-based analyses of static structures and molecular dynamics. Journal of Structural Biology 2020, 212 (3) , 107634. https://doi.org/10.1016/j.jsb.2020.107634
79. Kentaro Ihara, Masakatsu Hato, Takanori Nakane, Keitaro Yamashita, Tomomi Kimura-Someya, Toshiaki Hosaka, Yoshiko Ishizuka-Katsura, Rie Tanaka, Tomoyuki Tanaka, Michihiro Sugahara, Kunio Hirata, Masaki Yamamoto, Osamu Nureki, Kensuke Tono, Eriko Nango, So Iwata, Mikako Shirouzu. Isoprenoid-chained lipid EROCOC17+4: a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography. Scientific Reports 2020, 10 (1) https://doi.org/10.1038/s41598-020-76277-x
80. Abhinav R. Jain, Claire McGraw, Anne S. Robinson. The Specificity of Downstream Signaling for A1 and A2AR Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength. Biomedicines 2020, 8 (12) , 603. https://doi.org/10.3390/biomedicines8120603
81. Ming-Yue Lee, James Geiger, Andrii Ishchenko, Gye Won Han, Anton Barty, Thomas A. White, Cornelius Gati, Alexander Batyuk, Mark S. Hunter, Andrew Aquila, Sébastien Boutet, Uwe Weierstall, Vadim Cherezov, Wei Liu. Harnessing the power of an X-ray laser for serial crystallography of membrane proteins crystallized in lipidic cubic phase. IUCrJ 2020, 7 (6) , 976-984. https://doi.org/10.1107/S2052252520012701
82. Alexandra Borodovsky, Christine M Barbon, Yanjun Wang, Minwei Ye, Laura Prickett, Dinesh Chandra, Joseph Shaw, Nanhua Deng, Kris Sachsenmeier, James D Clarke, Bolan Linghu, Giles A Brown, James Brown, Miles Congreve, Robert KY Cheng, Andrew S Dore, Edward Hurrell, Wenlin Shao, Richard Woessner, Corinne Reimer, Lisa Drew, Stephen Fawell, Alwin G Schuller, Deanna A Mele. Small molecule AZD4635 inhibitor of A 2A R signaling rescues immune cell function including CD103 + dendritic cells enhancing anti-tumor immunity. Journal for ImmunoTherapy of Cancer 2020, 8 (2) , e000417. https://doi.org/10.1136/jitc-2019-000417
83. Veronica Salmaso, Kenneth A. Jacobson. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors. Biomolecules 2020, 10 (6) , 812. https://doi.org/10.3390/biom10060812
84. Pedro F.S. Toledo, Luis O. Viteri Jumbo, Sarah M. Rezende, Khalid Haddi, Bruno A. Silva, Tarcísio S. Mello, Terezinha M.C. Della Lucia, Raimundo W.S. Aguiar, Guy Smagghe, Eugenio E. Oliveira. Disentangling the ecotoxicological selectivity of clove essential oil against aphids and non-target ladybeetles. Science of The Total Environment 2020, 718 , 137328. https://doi.org/10.1016/j.scitotenv.2020.137328
85. Agustín Bruzzese, James A. R. Dalton, Jesús Giraldo, . Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions. PLOS Computational Biology 2020, 16 (4) , e1007818. https://doi.org/10.1371/journal.pcbi.1007818
86. Xavier Prasanna, Madhura Mohole, Amitabha Chattopadhyay, Durba Sengupta. Role of cholesterol-mediated effects in GPCR heterodimers. Chemistry and Physics of Lipids 2020, 227 , 104852. https://doi.org/10.1016/j.chemphyslip.2019.104852
87. Gemma Navarro, Angel Gonzalez, Stefano Campanacci, Rafael Rivas-Santisteban, Irene Reyes-Resina, Nil Casajuana-Martin, Arnau Cordomí, Leonardo Pardo, Rafael Franco. Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A2A receptor. Computational and Structural Biotechnology Journal 2020, 18 , 2723-2732. https://doi.org/10.1016/j.csbj.2020.09.028
88. Aliaa Abdelrahman, Swapnil G. Yerande, Vigneshwaran Namasivayam, Tim A. Klapschinski, Mohamad Wessam Alnouri, Ali El-Tayeb, Christa E. Müller. Substituted 4-phenylthiazoles: Development of potent and selective A1, A3 and dual A1/A3 adenosine receptor antagonists. European Journal of Medicinal Chemistry 2020, 186 , 111879. https://doi.org/10.1016/j.ejmech.2019.111879
89. Pedro Renault, Maxime Louet, Jacky Marie, Gilles Labesse, Nicolas Floquet. Molecular Dynamics Simulations of the Allosteric Modulation of the Adenosine A2a Receptor by a Mini-G Protein. Scientific Reports 2019, 9 (1) https://doi.org/10.1038/s41598-019-41980-x
90. Silvia Lovera, Alberto Cuzzolin, Sebastian Kelm, Gianni De Fabritiis, Zara A. Sands. Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots. Scientific Reports 2019, 9 (1) https://doi.org/10.1038/s41598-019-50752-6
91. Antonella Ciancetta, Priscila Rubio, David I. Lieberman, Kenneth A. Jacobson. A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states. Journal of Computer-Aided Molecular Design 2019, 33 (11) , 983-996. https://doi.org/10.1007/s10822-019-00246-4
92. Omar H.A. Al-Attraqchi, Mahesh Attimarad, Katharigatta N. Venugopala, Anroop Nair, Noor H.A. Al-Attraqchi. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. Current Pharmaceutical Design 2019, 25 (25) , 2716-2740. https://doi.org/10.2174/1381612825666190716113444
93. Min Zhang, Shiyong Fan, Xinbo Zhou, Fei Xie, Song Li, Wu Zhong. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A2A adenosine receptor ligands. European Journal of Medicinal Chemistry 2019, 179 , 310-324. https://doi.org/10.1016/j.ejmech.2019.06.050
94. Maicol Bissaro, Giovanni Bolcato, Giuseppe Deganutti, Mattia Sturlese, Stefano Moro. Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A2A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations. Molecules 2019, 24 (15) , 2752. https://doi.org/10.3390/molecules24152752
95. Mohammed Nooraldeen Mahmod Al-Qattan, Mohd Nizam Mordi. Molecular Basis of Modulating Adenosine Receptors Activities. Current Pharmaceutical Design 2019, 25 (7) , 817-831. https://doi.org/10.2174/1381612825666190304122624
96. Nizar A. Al-Shar'i, Qosay A. Al-Balas. Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends. Current Pharmaceutical Design 2019, 25 (7) , 783-816. https://doi.org/10.2174/1381612825666190304123414
97. Lee H. Wink, Daniel L. Baker, Judith A. Cole, Abby L. Parrill. A benchmark study of loop modeling methods applied to G protein-coupled receptors. Journal of Computer-Aided Molecular Design 2019, 33 (6) , 573-595. https://doi.org/10.1007/s10822-019-00196-x
98. Rita C. Acúrcio, Anna Scomparin, Ronit Satchi‐Fainaro, Helena F. Florindo, Rita C. Guedes. Computer‐aided drug design in new druggable targets for the next generation of immune‐oncology therapies. WIREs Computational Molecular Science 2019, 9 (3) https://doi.org/10.1002/wcms.1397
99. Claire McGraw, Lewen Yang, Ilya Levental, Edward Lyman, Anne Skaja Robinson. Membrane cholesterol depletion reduces downstream signaling activity of the adenosine A2A receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes 2019, 1861 (4) , 760-767. https://doi.org/10.1016/j.bbamem.2019.01.001
100. David A. Sykes, Leigh A. Stoddart, Laura E. Kilpatrick, Stephen J. Hill. Binding kinetics of ligands acting at GPCRs. Molecular and Cellular Endocrinology 2019, 485 , 9-19. https://doi.org/10.1016/j.mce.2019.01.018